Mogen Inc. Essay

EXECUTIVE SUMMARYIn 2006, Merrill Lynch become the campaign book runner for a $5 billion convertible seize issue for MoGen, Inc., which was the single-largest convertible bond issuance in history. Merrill Lynchs Equity Derivatives Group needed to convince MoGens management of the exceed coupon rate and conversion premium for MoGen and the potential investors in the issue. landMoGen, Inc was one of the leading company in the biotechnology industry. MoGen (Molecular Genetics) emerged with two of the archetypical biologically derrived human therapeutic medicates that helped to offset the damaging effects from chemotherapy for cancer patients undergoing treatment. This products were the first blockbuster drugs to emerge from the nascent biotechnology industry.SWOT compendium1.Strength Leading company in biotechnology industry.Succesfully treating the patient as tumefy as making the company competitive leader in drug quality.Credit rating A+2.Opportunity Tren gaya hidup masyarakat yang mulai mementingkan kesehatanMunculnya berbagai gangguan kesehatan di zaman modern3.Threat Faced indecision of new product creation.Competitive threat of follow-on biologics or biosimilar began emerging.